Inventor · disambiguated record
Antonio Ricci
Also filed as: RICCI ANTONIO
58 granted patents·22 pending applications·211 citations·filing 1976–2025
98Inventor score
Files withHOFFMANN LA ROCHE45FRESENIUS KABI IPSUM S R L11DIESSE DIAGNOSTICA10C4 THERAPEUTICS INC4GREEN LUKE2
Top patents by PatentIndex Score
80 records- 0196US12209091B2Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancersHOFFMANN LA ROCHE·Filed 2020·Granted Jan 28, 2025·7 cites·30 claims
- 0295US11673902B2Isoindolinone and indazole compounds for the degradation of EGFRC4 THERAPEUTICS INC·Filed 2022·Granted Jun 13, 2023·3 cites·29 claims
- 0394US11708354B22-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 25, 2023·3 cites·16 claims
- 0493US12371442B2Isoindolinone and indazole compounds for the degradation of EGFRC4 THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·1 cites·28 claims
- 0592US12344613B2EGFR inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Jul 1, 2025·3 cites·10 claims
- 0687US10882848B22-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compoundsHOFFMANN LA ROCHE·Filed 2019·Granted Jan 5, 2021·3 cites·15 claims
- 0786US11117890B2Substituted isoindole allosteric EGFR inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Sep 14, 2021·3 cites·21 claims
- 0886US10189848B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jan 29, 2019·4 cites·18 claims
- 0986US8420661B2Arylethynyl derivativesGREEN LUKE·Filed 2011·Granted Apr 16, 2013·8 cites·6 claims
- 1084US11242349B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2020·Granted Feb 8, 2022·1 cites·4 claims
- 1184US10414830B2Crystalline forms of per-chloro-γ-cyclodextrinesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Sep 17, 2019·2 cites·11 claims
- 1283US10065956B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Sep 4, 2018·4 cites·12 claims
- 1383US9695128B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Jul 4, 2017·4 cites·8 claims
- 1483US8513273B2Arylethynyl derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Aug 20, 2013·4 cites·6 claims
- 1582US10414829B2Process for the preparation of sugammadex and its intermediatesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Sep 17, 2019·2 cites·12 claims
- 1682US9725416B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Aug 8, 2017·4 cites·12 claims
- 1782US8618296B2Arylethynyl derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Dec 31, 2013·4 cites·6 claims
- 1881US8716316B2Positive allosteric modulators (PAM)HOFFMANN LA ROCHE·Filed 2013·Granted May 6, 2014·4 cites·14 claims
- 1980US12486290B2Isoindolinone and indazole compounds for the degradation of EGFRC4 THERAPEUTICS INC·Filed 2025·Granted Dec 2, 2025·0 cites·30 claims
- 2079US9682959B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Jun 20, 2017·2 cites·3 claims
- 2179US8969338B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Mar 3, 2015·4 cites·12 claims
- 2278US8648088B2Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivativesJAESCHKE GEORG·Filed 2012·Granted Feb 11, 2014·4 cites·13 claims
- 2378US2025289824A1Egfr inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2477US10577433B2Process for the preparation of sugammadexFRESENIUS KABI IPSUM S R L·Filed 2017·Granted Mar 3, 2020·1 cites·17 claims
- 2577US9359301B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·2 cites·10 claims
- 2677US9315498B2Arlethynyl derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Apr 19, 2016·2 cites·8 claims
- 2777US8772300B2Phenyl or pyridinyl-ethynyl derivativesJAESCHKE GEORG·Filed 2012·Granted Jul 8, 2014·4 cites·14 claims
- 2875US9751856B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Sep 5, 2017·1 cites·3 claims
- 2974US12145940B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2022·Granted Nov 19, 2024·0 cites·4 claims
- 3073US8389536B2Positive allosteric modulators (PAM)GREEN LUKE·Filed 2010·Granted Mar 5, 2013·2 cites·13 claims
- 3173US8211381B2Device for performing analyses on biological fluids and related methodRICCI ANTONIO·Filed 2004·Granted Jul 3, 2012·18 cites·45 claims
- 3272US12006323B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2021·Granted Jun 11, 2024·0 cites·16 claims
- 3372US2022135571A1Therapeutic egfr inhibitorsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3471US12195413B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 3565US12479849B2EGFR inhibitors for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Nov 25, 2025·0 cites·8 claims
- 3665US10385020B2Process intermediates and methods for the preparation of process intermediates for the synthesis of argatroban monohydrateLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2018·Granted Aug 20, 2019·0 cites·6 claims
- 3765US6387327B1Apparatus for the preparation and the performance of sedimentation velocity tests on organic liquids and other substancesDIESSE DIAGNOSTICA·Filed 1997·Granted May 14, 2002·23 cites·19 claims
- 3865US2022112199A1Egfr inhibitor for medical useHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3964US6773675B2Test tube for biological analyses of organic liquids using electro-optical equipmentDIESSE DIAGNOSTICA·Filed 2001·Granted Aug 10, 2004·5 cites·28 claims
- 4063US12098218B2Process for the manufacture of degarelix and its intermediatesFRESENIUS KABI IPSUM S R L·Filed 2021·Granted Sep 24, 2024·0 cites·13 claims
- 4163US11059766B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jul 13, 2021·0 cites·18 claims
- 4263US2024158418A1EGFR Degraders to Treat Cancer Metastasis to the Brain or CNSC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4362US2025296931A1Novel isoquinolinone, pyrrolopyridinone and thienopyridinone sulfonamide derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4462US2025313565A1New indazole derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4562US2024025883A1Pyrimidin-2-yl sulfonamide derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4661US11034699B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jun 15, 2021·0 cites·16 claims
- 4760US5420018ADevice for the preservation and analysis of samples, in particular for bacteriological examinations, isolation of micro-organisms and development of isolation colonies, and a method for seeding the samples onto a culture medium in said deviceDIESSE DIAGNOSTICA·Filed 1993·Granted May 30, 1995·13 cites·18 claims
- 4859US9994526B2Process intermediates and methods for the preparation of process intermediates for the synthesis of argatroban monohydrateLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2016·Granted Jun 12, 2018·0 cites·24 claims
- 4958US2022315591A1New egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 5057US2019144458A1Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Antonio Ricci files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →